![Eledon Pharmaceuticals Inc](/common/images/company/N_ELDN.png)
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc.Β (βEledonβ) (Nasdaq: ELDN) today announced that the Companyβs management team will be hosting one-on-one meetings at...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 7.56972111554 | 2.51 | 2.85 | 2.47 | 65905 | 2.74855805 | CS |
4 | 0.06 | 2.27272727273 | 2.64 | 2.85 | 2.3 | 70345 | 2.56198557 | CS |
12 | 0.63 | 30.4347826087 | 2.07 | 3.349 | 2 | 205146 | 2.59595974 | CS |
26 | 0.99 | 57.8947368421 | 1.71 | 3.349 | 1.5199 | 140519 | 2.34792778 | CS |
52 | 1.27 | 88.8111888112 | 1.43 | 3.349 | 1.07 | 111167 | 2.01116459 | CS |
156 | -3.9 | -59.0909090909 | 6.6 | 8.49 | 1.07 | 83829 | 2.86825791 | CS |
260 | -13.1 | -82.9113924051 | 15.8 | 22.91 | 1.07 | 79888 | 3.93531469 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.